Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

ChatGPT 5 Update Rollout Could Cause 'Probable Hiccups And Capacity Crunches', OpenAI CEO Sam Altman...

ChatGPT 5 Update Rollout Could Cause 'Probable Hiccups And Capacity Crunches', OpenAI CEO Sam Altman...

Aurobindo Pharma Reports 10.2% Drop In Net Profit To ₹824.2 Crore For The First Quarter

Aurobindo Pharma Reports 10.2% Drop In Net Profit To ₹824.2 Crore For The First Quarter

India’s Only Integrated Zinc Producer, Hindustan Zinc, Partners With GreenLine Mobility Solutions;...

India’s Only Integrated Zinc Producer, Hindustan Zinc, Partners With GreenLine Mobility Solutions;...

Market Outlook: Technical Call Of The Day & Top 5 Stocks In Focus For 5th Aug 2025

Market Outlook: Technical Call Of The Day & Top 5 Stocks In Focus For 5th Aug 2025

India’s Exports To US May Fall 30% To USD 60.6 Billion This Fiscal Due To Trump Tariffs: GTRI

India’s Exports To US May Fall 30% To USD 60.6 Billion This Fiscal Due To Trump Tariffs: GTRI